ARQT - Financial Reports List - Arcutis Biotherapeutics, Inc. - IntrinsicAlpha

Arcutis Biotherapeutics, Inc. ARQT

Healthcare - Biotechnology - NASDAQ - US

$ 13.75

4 %

$ 1.63 B

Market Cap

-11.66

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	427.58%	83.72%	87.52%
Annual Report	FY	10-K	2024-12-31	229.74%	46.58%	46.75%
Quarterly Report	Q3	8-K	2024-09-30	17.44%	7.21%	-5.86%
Quarterly Report	Q2	8-K	2024-06-30	494.57%	26.28%	24.99%
Quarterly Report	Q1	8-K	2024-03-31	1682.42%	55.63%	58.54%
Quarterly Report	Q4	8-K	2023-12-31	356.81%	12.34%	10.60%
Annual Report	FY	10-K	2023-12-31	1517.09%	18.41%	20.07%
Quarterly Report	Q3	8-K	2023-09-30	5156.41%	59.55%	64.77%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	-2.91%	-1.42%
Quarterly Report	Q1	8-K	2023-03-31	0.00%	-20.78%	-21.77%

1